Internal Medicine, Hematology & Oncology · Cortlandt Manor, NY
NPI
1588825962
Since 2008
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
1978 Crompond Rd Ste G1
Cortlandt Manor, NY, 10567
Phone (914) 293-8400
Groups this clinician bills Medicare through
Medicare paid, 2024
$225K
3,118 services
Medicare patients, 2024
381
Average age 76
Drug cost, 2024
$3.3M
1,432 prescriptions
Company payments, 2025
$19.24
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Vinit Karur was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 894 times for 291 patients. In total Vinit Karur billed 3,118 services in 12 codes, and Medicare paid $225K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-12-08.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 894 | 291 | $15.58 | $14K |
| 36415 Venipuncture Blood Collection | Office | 735 | 266 | $8.52 | $6,263 |
| 99215 Office E&M - Established | Office | 583 | 187 | $169.44 | $99K |
| 99214 Office E&M - Established | Office | 437 | 230 | $115.36 | $50K |
| 99232 Hospital E&M - Subsequent | Facility | 243 | 63 | $74.87 | $18K |
| 99223 Hospital E&M - Initial | Facility | 118 | 99 | $163.85 | $19K |
| 99205 Office E&M - New | Office | 73 | 73 | $204.94 | $15K |
| 99233 Hospital E&M - Subsequent | Facility | 27 | 20 | $112.79 | $3,045 |
By year: 2022 $138K for 1,603 services; 2023 $225K for 2,582 services; 2024 $225K for 3,118 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 735 | 266 | $8.52 | $6,263 |
Medicare prescription drug claims, 2024
In 2024, the drug Vinit Karur prescribed most often to Medicare patients was Abiraterone Acetate, with 116 prescriptions and refills. In total Vinit Karur wrote 1,432 Medicare prescriptions that cost $3.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Abiraterone Acetate Generic | 116 | 120 | 19 | $515K |
| Anastrozole Generic | 112 | 311 | 41 | $2,357 |
| Prednisone Generic | 78 | 176 | 29 | $355 |
| Letrozole Generic | 77 | 232 | 27 | $1,744 |
| Prochlorperazine Maleate Generic | 66 | 66 | 39 | $707 |
| Eliquis Apixaban | 66 | 110 | 17 | $62K |
| Ondansetron Hcl Generic | 54 | 56 | 41 | $745 |
| Dexamethasone Generic | 53 | 65 | 43 | $1,014 |
| Exemestane Generic | 31 | 71 | Under 11 | $6,805 |
| Tamoxifen Citrate Generic | 30 | 90 | Under 11 | $954 |
| Lenalidomide Generic | 28 | 28 | Under 11 | $435K |
| Valacyclovir Valacyclovir Hcl | 26 | 78 | Under 11 | $1,484 |
| Imbruvica Ibrutinib | 25 | 25 | Under 11 | $410K |
| Xarelto Rivaroxaban | 25 | 57 | Under 11 | $32K |
| Nubeqa Darolutamide | 24 | 24 | Under 11 | $298K |
Brand drugs: - claims; generic drugs: 1,108 claims; opioid claims: 31.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Vinit Karur $19.24 ($19.24 in general payments such as food, travel and fees) from 1 company. The largest payer was Daiichi Sankyo Inc. with $19.24.
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. 4568.T | 1 | $19.24 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.